Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy.
about
Aptamers: A Feasible Technology in Cancer ImmunotherapyAptamers: A New Technological Platform in Cancer ImmunotherapyNew Modalities for Challenging Targets in Drug Discovery.Aptamers for CD Antigens: From Cell Profiling to Activity Modulation.Emerging cancer-specific therapeutic aptamers.Identification of LAG3 high affinity aptamers by HT-SELEX and Conserved Motif Accumulation (CMA).Targeting the anion exchanger 2 with specific peptides as a new therapeutic approach in B lymphoid neoplasms.Aptamers: novelty tools for cancer biology.
P2860
Q26740303-D12C4516-3B32-40E8-A0DC-638AB510CB2AQ28068981-8BB858EF-BBB4-4421-B6E4-B18C977FFA99Q38289100-876513DD-F46E-41D1-885D-D66939A2B0A7Q39191316-0664C0A0-595A-477E-9C09-374370A9233DQ39425770-405A97DD-1AE7-4DDA-99DE-530405E89778Q42362135-3DAF6044-9760-42A7-8F5E-5E00B6FB2880Q47388658-E6FEE235-9C04-4A0F-97E0-5ABCDA4FB0F9Q55285633-D2CF30B3-7E04-43E7-A082-096B6C0A29B7
P2860
Targeting inhibition of Foxp3 by a CD28 2'-Fluro oligonucleotide aptamer conjugated to P60-peptide enhances active cancer immunotherapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Targeting inhibition of Foxp3 ...... s active cancer immunotherapy.
@en
Targeting inhibition of Foxp3 ...... s active cancer immunotherapy.
@nl
type
label
Targeting inhibition of Foxp3 ...... s active cancer immunotherapy.
@en
Targeting inhibition of Foxp3 ...... s active cancer immunotherapy.
@nl
prefLabel
Targeting inhibition of Foxp3 ...... s active cancer immunotherapy.
@en
Targeting inhibition of Foxp3 ...... s active cancer immunotherapy.
@nl
P2093
P1433
P1476
Targeting inhibition of Foxp3 ...... s active cancer immunotherapy.
@en
P2093
Helena Villanueva
Mario Martínez Soldevilla
Maurizio Bendandi
Noelia Casares
Teresa Lozano
P356
10.1016/J.BIOMATERIALS.2016.03.007
P577
2016-03-08T00:00:00Z